8-K/A 1 doc1.txt SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 8-K/A CURRENT REPORT PURSUANT TO SECTION 13 OR 15(D) OF THE SECURITIES EXCHANGE ACT OF 1934 NOVEMBER 17, 2003 DATE OF REPORT (DATE OF EARLIEST EVENT REPORTED) NEW BRUNSWICK SCIENTIFIC CO., INC. (EXACT NAME OF REGISTRANT AS SPECIFIED IN CHARTER) NEW JERSEY 0-6994 22-1630072 (STATE OR OTHER JURISDICTION OF (COMMISSION FILE NUMBER) (IRS EMPLOYER IDENTIFICATION NO.) INCORPORATION) 44 TALMADGE ROAD, EDISON, NJ 08818-4005 (ADDRESS OF PRINCIPAL EXECUTIVE OFFICES) (ZIP CODE) REGISTRANT'S TELEPHONE NUMBER, INCLUDING AREA CODE: (732) 287-1200 (FORMER NAME OR FORMER ADDRESS, IF CHANGED SINCE LAST REPORT) ITEM 2. ACQUISITION OR DISPOSITION OF ASSETS. THE FOLLOWING INFORMATION IS FURNISHED PURSUANT TO ITEM 2 "ACQUISITION OR DISPOSITION OF ASSETS": ON NOVEMBER 17, 2003, NEW BRUNSWICK SCIENTIFIC CO., INC. ISSUED A PRESS RELEASE REPORTING ITS ACQUISITION OF RS BIOTECH LTD. THE PRESS RELEASE IS ATTACHED HERETO AS EXHIBIT 99.1. EXHIBIT DESCRIPTION 99.1 PRESS RELEASE ISSUED NOVEMBER 17, 2003 SIGNATURES PURSUANT TO THE REQUIREMENTS OF THE SECURITIES EXCHANGE ACT OF 1934, THE REGISTRANT HAD DULY CAUSED THIS REPORT TO BE SIGNED ON ITS BEHALF BY THE UNDERSIGNED HEREUNTO DULY AUTHORIZED. NEW BRUNSWICK SCIENTIFIC CO., INC. DATE: NOVEMBER 17, 2003 BY: /S/SAMUEL EICHENBAUM SAMUEL EICHENBAUM VICE PRESIDENT, FINANCE AND CHIEF FINANCIAL OFFICER